The impact of early anti-SARS-CoV-2 antibody production on the length of hospitalization stay among COVID-19 patients.

ABSTRACT: COVID-19 has challenged the scientific community in the search for biological markers and information that can contribute to the early management of the severe disease. Given the global scale of COVID-19, including reports of reinfection even in the presence of effective vaccines; consequently, the eradication of SARS-CoV-2 is far from happening. This study aimed to characterize the neutralizing antibody (Nab) geometric mean titers (GMTs) in hospitalized patients with COVID-19 and to evaluate the association with length of stay, comorbidities, and patient outcome. Among the 103 participants, 84 (81.5%) had some previous conditions associated with worsening health and 34 (33%) died. We found that neutralization potency varied greatly across individuals and was significantly higher in patien

SUBMITTER: de Almeida DV 

PROVIDER: S-EPMC10715214 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature